Department of Cardiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing, China.
Mol Genet Genomic Med. 2019 Nov;7(11):e949. doi: 10.1002/mgg3.949. Epub 2019 Sep 3.
Biallelic variants of the CASQ2 are known to cause the autosomal recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disease that predisposes young individuals to syncope and sudden cardiac death. To date, only about 24 CASQ2 variants have been reported in association with CPVT pathogenesis; furthermore, studies in Asians, especially in the Chinese population, are relatively rare. The aim of this study was to detect CASQ2 variants in Chinese patients with CPVT.
We used targeted next-generation sequencing (NGS) to identify CASQ2 variants in Chinese patients with CPVT. A screening process was performed to prioritize rare variants of potential functional significance. Sanger sequencing was conducted to conform the candidate variants and determine the parental origin.
We identified seven different CASQ2 variants, of which three (c.1074_1075delinsC, c.1175_1178delACAG, and c.838+1G>A) have not been previously reported. The variants exhibited autosomal recessive inheritance, and were detected in four unrelated Chinese families with CPVT. They included a nonsense variant c.97C>T (p.R33*) and a missense variant c.748C>T (p.R250C) in Family 1 with three CPVT patients; two heterozygous frameshift variants, c.1074_1075delinsC (p.G359Afs12) and c.1175_1178delACAG (p.D392Vfs84), in Family 2 with one CPVT patient; one pathogenic homozygous variant c.98G>A (p.R33Q) of CASQ2 in the CPVT patient of Family 3; and two heterozygous splicing variants, (c.532+1G>A) and (c.838+1G>A), in Family 4 with one CPVT patient.
To our knowledge, this is the first systematic study of Chinese children with CASQ2 variants. Our work further expands the genetic spectrum of CASQ2-associated CPVT.
已知 CASQ2 的双等位基因变异可导致常染色体隐性形式的儿茶酚胺多形性室性心动过速(CPVT),这是一种遗传性疾病,使年轻人容易出现晕厥和心源性猝死。迄今为止,仅报道了约 24 种与 CPVT 发病机制相关的 CASQ2 变异;此外,在亚洲人,尤其是中国人中的研究相对较少。本研究旨在检测 CPVT 中国患者的 CASQ2 变异。
我们使用靶向下一代测序(NGS)来鉴定 CPVT 中国患者的 CASQ2 变异。进行了筛选过程,以优先考虑具有潜在功能意义的罕见变异。进行 Sanger 测序以确认候选变异并确定亲本来源。
我们鉴定了七种不同的 CASQ2 变异,其中三种(c.1074_1075delinsC、c.1175_1178delACAG 和 c.838+1G>A)以前未报道过。这些变异表现为常染色体隐性遗传,并在四个无关的 CPVT 中国家庭中检测到。它们包括在有三个 CPVT 患者的家庭 1 中发现的无义变异 c.97C>T(p.R33*)和错义变异 c.748C>T(p.R250C);在 CPVT 患者的家庭 2 中发现了两个杂合框移变异 c.1074_1075delinsC(p.G359Afs12)和 c.1175_1178delACAG(p.D392Vfs84);在 CPVT 患者的家庭 3 中发现了 CASQ2 的致病纯合变异 c.98G>A(p.R33Q);在 CPVT 患者的家庭 4 中发现了两个杂合剪接变异 c.532+1G>A 和 c.838+1G>A。
据我们所知,这是首次对中国儿童 CASQ2 变异进行的系统研究。我们的工作进一步扩大了 CASQ2 相关 CPVT 的遗传谱。